These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16898974)

  • 1. Early onset multiple alloimmunization (anti-E and anti-Jkb) in a thalassaemic.
    Thakral B; Saluja K; Sharma RR; Marwaha N; Marwaha RK
    Clin Lab Haematol; 2006 Aug; 28(4):286-7. PubMed ID: 16898974
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a computer crossmatch in the absence of an immediate-spin antibody screen adequate for persons identified to be at increased risk of forming new blood group antibodies?
    Sandler SG; Abedalthagafi M; Langeberg A
    Transfusion; 2008 Oct; 48(10):2265-6. PubMed ID: 18928510
    [No Abstract]   [Full Text] [Related]  

  • 3. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
    Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
    Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
    El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
    Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-D alloimmunization after transfusion of D+ red blood cells.
    Cid J; Ramiro L
    Transfusion; 2009 Jan; 49(1):186-7; author reply 187. PubMed ID: 19140813
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion for patients with immunohematological problems].
    Tohyama H; Uchikawa M
    Rinsho Byori; 1982 Oct; 30(10):1089-95. PubMed ID: 6763640
    [No Abstract]   [Full Text] [Related]  

  • 8. Allosensitization in patients receiving multiple blood transfusions.
    Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD
    Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province, Egypt.
    Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
    Transfus Apher Sci; 2015 Aug; 53(1):52-7. PubMed ID: 25817267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloimmunization against human platelet antigen 2 (HPA2) in a series of multi-transfused beta-thalassemia patients.
    Tazzari PL; Ricci F; Tassi C; Bontadini A; Fruet F; Conte R
    Haematologica; 1998 Aug; 83(8):765-6. PubMed ID: 9793272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the clinical significance of blood group alloantibodies that are causing problems in pretransfusion testing.
    Garratty G
    Vox Sang; 1998; 74 Suppl 2():285-90. PubMed ID: 9704458
    [No Abstract]   [Full Text] [Related]  

  • 12. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
    Karimi M; Nikrooz P; Kashef S; Jamalian N; Davatolhagh Z
    Int J Lab Hematol; 2007 Oct; 29(5):321-6. PubMed ID: 17824911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current problems of blood transfusion. Responsibility of the physician in transfusion].
    Schönitzer D; Rosmanith P; Kilga-Nogler S
    Infusionsther Klin Ernahr; 1985 Aug; 12(4):170-4. PubMed ID: 4066002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood transfusion and monitoring. Immediate transfusion reactions. Erythrocyte transfusion].
    Riche H
    Soins; 1996 Apr; (605):23-6. PubMed ID: 8716245
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute pancreatitis associated with massive hemolysis due to a delayed hemolytic transfusion reaction.
    Szymanski I; Seder R
    Transfusion; 2005 Oct; 45(10):1691-2. PubMed ID: 16181225
    [No Abstract]   [Full Text] [Related]  

  • 16. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom.
    Mijovic A; Perera IG; Thein SL
    Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed haemolytic transfusion reaction due to anti-Jkb in a patient with non-Hodgkin's lymphoma-transient nature of anti-Jkb and the importance of early serological diagnosis.
    Hussain SS; Ebbs AM; Curtin NJ; Keidan AJ
    Transfus Med; 2007 Jun; 17(3):197-9. PubMed ID: 17561862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible insensitivity of the polybrene antibody screen to detect anti-Jka.
    Liu F; Liu J
    Ann Clin Lab Sci; 2006; 36(1):101-2. PubMed ID: 16501244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neonatal blood group incompatibility due to anti-M antibodies].
    Hoffmann JJ; Hutter AP; Loomans AA; Tielens AG
    Ned Tijdschr Geneeskd; 1991 May; 135(18):805-7. PubMed ID: 2052099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan.
    Chao YH; Wu KH; Lu JJ; Shih MC; Peng CT; Chang CW
    Blood Transfus; 2013 Jan; 11(1):71-4. PubMed ID: 22790261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.